Norway· NO-ID_D4EF2589-4E5E-48BD-BE3B-C38919DACD05
Synalar
A fluocinolone acetonide product containing fluocinolone acetonide, registered in Norway by Bioglan AB. The same ATC class is registered in 7 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Fluocinolone acetonide is registered in 7 of 19 countries.
Countries holding a registration under ATC D07AC04 (fluocinolone acetonide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Fluocinolone acetonide · ATC D07AC04
7 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Fluocinolone Acetonide
- Manufacturer
- Bioglan AB
- Country
- Norway (NO)
- ATC code
- D07AC04
- ATC class
- Fluocinolone acetonide
- Defined daily dose
- 0.3 mg, T
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_D4EF2589-4E5E-48BD-BE3B-C38919DACD05
- no_varenummer09819930NOK 84.1
- gtin7350057840443
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
10 interactions on record for fluocinolone acetonide.
Graded by severity as the source publishes them — 10 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluocinolone acetonide · interactions on record
10 records
Same medicine, other countries
Fluocinolone acetonide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDerma-Smoothe/FSRoyal Pharmaceuticals, LLC
- PolandFlucinarInPharm Sp. z o.o.
- United KingdomILUVIEN 190microgram intravitreal implant in applicatorAlimera Sciences Ltd
- FinlandIluvienAbacus Medicine A/S
- Japanフルオシノロンアセトニド田辺ファーマ
- GermanyFlucinarAbanta Pharma Gmbh
- CzechiaFLUCINARBausch Health Ireland Limited, Dublin
- SwedenIluvien 190 mikrogram Intravitrealt implantat i applikatorAlimera Sciences Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Iluvien
- Belgium · Iluvien
- Bulgaria · Абрикорт, Флуцинар
- Czechia · Flucinar, Iluvien
- Germany · Flucinar, Iluvien
- Denmark · Iluvien, Otazem
- Spain · Ekzem, Fluocid Forte
- Finland · Iluvien, Otazem
- France · Iluvien
- United Kingdom (Northern Ireland) · Iluvien, Synalar
- Greece · Synalar Simple
- Hungary · Flucinar
- Ireland · Iluvien
- Italy · Ekzem, Fluovitef
- Lithuania · Flucinar
- Luxembourg · Iluvien
- Latvia · Flucinar
- Netherlands · Iluvien
- Poland · Flucinar, Iluvien
- Portugal · Ekzem, Iluvien
- Romania · Fluocinolon Acetonid Laropharm
- Sweden · Iluvien, Otazem
- Slovakia · Flucinar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dac5ee36-71a2-4cce-8a1a-f75ee1d34bd1 GET /v1/drugs/dac5ee36-71a2-4cce-8a1a-f75ee1d34bd1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gel",
"source": "fest",
"status": "A",
"atc_name": "Fluocinolonacetonid",
"merkevare_id": "ID_D4EF2589-4E5E-48BD-BE3B-C38919DACD05",
"name_form_strength": "Synalar gel 0,025 %",
"prescription_group": "C"
}See everything about fluocinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.